Cargando…

Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016–2018

PURPOSE: To examine the live birth and other outcomes reported with and without preimplantation genetic testing for aneuploidy (PGT-A) in the United Kingdom (UK) Human Embryology and Fertilization Authority (HFEA) data collection. METHODS: A retrospective cohort analysis was conducted following free...

Descripción completa

Detalles Bibliográficos
Autores principales: Sanders, Kathryn D., Silvestri, Giuseppe, Gordon, Tony, Griffin, Darren K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Springer US 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666405/
https://www.ncbi.nlm.nih.gov/pubmed/34766235
http://dx.doi.org/10.1007/s10815-021-02349-0
_version_ 1784614198663184384
author Sanders, Kathryn D.
Silvestri, Giuseppe
Gordon, Tony
Griffin, Darren K.
author_facet Sanders, Kathryn D.
Silvestri, Giuseppe
Gordon, Tony
Griffin, Darren K.
author_sort Sanders, Kathryn D.
collection PubMed
description PURPOSE: To examine the live birth and other outcomes reported with and without preimplantation genetic testing for aneuploidy (PGT-A) in the United Kingdom (UK) Human Embryology and Fertilization Authority (HFEA) data collection. METHODS: A retrospective cohort analysis was conducted following freedom of information (FoI) requests to the HFEA for the PGT-A and non-PGT-A cycle outcomes for 2016–2018. Statistical analysis of differences between PGT-A and non-PGT-A cycles was performed. Other than grouping by maternal age, no further confounders were controlled for; fresh and frozen transfers were included. RESULTS: Outcomes collected between 2016 and 2018 included total number of cycles, cycles with no embryo transfer, total number of embryos transferred, live birth rate (LBR) per embryo transferred and live birth rate per treatment cycle. Data was available for 2464 PGT-A out of a total 190,010 cycles. LBR per embryo transferred and LBR per treatment cycle (including cycles with no transfer) were significantly higher for all PGT-A vs non-PGT-A age groups (including under 35), with nearly all single embryo transfers (SET) after PGT-A (significantly more in non-PGT-A) and a reduced number of transfers per live birth particularly for cycles with maternal age over 40 years. CONCLUSION: The retrospective study provides strong evidence for the benefits of PGT-A in terms of live births per embryo transferred and per cycle started but is limited in terms of matching PGT-A and non-PGT-A cohorts (e.g. in future studies, other confounders could be controlled for). This data challenges the HFEA “red traffic light” guidance that states there is “no evidence that PGT-A is effective or safe” and hence suggests the statement be revisited in the light of this and other new data. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10815-021-02349-0.
format Online
Article
Text
id pubmed-8666405
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher Springer US
record_format MEDLINE/PubMed
spelling pubmed-86664052021-12-27 Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016–2018 Sanders, Kathryn D. Silvestri, Giuseppe Gordon, Tony Griffin, Darren K. J Assist Reprod Genet Genetics PURPOSE: To examine the live birth and other outcomes reported with and without preimplantation genetic testing for aneuploidy (PGT-A) in the United Kingdom (UK) Human Embryology and Fertilization Authority (HFEA) data collection. METHODS: A retrospective cohort analysis was conducted following freedom of information (FoI) requests to the HFEA for the PGT-A and non-PGT-A cycle outcomes for 2016–2018. Statistical analysis of differences between PGT-A and non-PGT-A cycles was performed. Other than grouping by maternal age, no further confounders were controlled for; fresh and frozen transfers were included. RESULTS: Outcomes collected between 2016 and 2018 included total number of cycles, cycles with no embryo transfer, total number of embryos transferred, live birth rate (LBR) per embryo transferred and live birth rate per treatment cycle. Data was available for 2464 PGT-A out of a total 190,010 cycles. LBR per embryo transferred and LBR per treatment cycle (including cycles with no transfer) were significantly higher for all PGT-A vs non-PGT-A age groups (including under 35), with nearly all single embryo transfers (SET) after PGT-A (significantly more in non-PGT-A) and a reduced number of transfers per live birth particularly for cycles with maternal age over 40 years. CONCLUSION: The retrospective study provides strong evidence for the benefits of PGT-A in terms of live births per embryo transferred and per cycle started but is limited in terms of matching PGT-A and non-PGT-A cohorts (e.g. in future studies, other confounders could be controlled for). This data challenges the HFEA “red traffic light” guidance that states there is “no evidence that PGT-A is effective or safe” and hence suggests the statement be revisited in the light of this and other new data. SUPPLEMENTARY INFORMATION: The online version contains supplementary material available at 10.1007/s10815-021-02349-0. Springer US 2021-11-12 2021-12 /pmc/articles/PMC8666405/ /pubmed/34766235 http://dx.doi.org/10.1007/s10815-021-02349-0 Text en © The Author(s) 2021 https://creativecommons.org/licenses/by/4.0/Open AccessThis article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article's Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article's Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) .
spellingShingle Genetics
Sanders, Kathryn D.
Silvestri, Giuseppe
Gordon, Tony
Griffin, Darren K.
Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016–2018
title Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016–2018
title_full Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016–2018
title_fullStr Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016–2018
title_full_unstemmed Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016–2018
title_short Analysis of IVF live birth outcomes with and without preimplantation genetic testing for aneuploidy (PGT-A): UK Human Fertilisation and Embryology Authority data collection 2016–2018
title_sort analysis of ivf live birth outcomes with and without preimplantation genetic testing for aneuploidy (pgt-a): uk human fertilisation and embryology authority data collection 2016–2018
topic Genetics
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8666405/
https://www.ncbi.nlm.nih.gov/pubmed/34766235
http://dx.doi.org/10.1007/s10815-021-02349-0
work_keys_str_mv AT sanderskathrynd analysisofivflivebirthoutcomeswithandwithoutpreimplantationgenetictestingforaneuploidypgtaukhumanfertilisationandembryologyauthoritydatacollection20162018
AT silvestrigiuseppe analysisofivflivebirthoutcomeswithandwithoutpreimplantationgenetictestingforaneuploidypgtaukhumanfertilisationandembryologyauthoritydatacollection20162018
AT gordontony analysisofivflivebirthoutcomeswithandwithoutpreimplantationgenetictestingforaneuploidypgtaukhumanfertilisationandembryologyauthoritydatacollection20162018
AT griffindarrenk analysisofivflivebirthoutcomeswithandwithoutpreimplantationgenetictestingforaneuploidypgtaukhumanfertilisationandembryologyauthoritydatacollection20162018